Recruiting
Phase 2

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Sponsor:

St. Jude Children's Research Hospital

Code:

NCT06533748

Conditions

Acute Lymphoblastic Leukemia

Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 1 - 18

Healthy Volunteers: Not accepted

Interventions

Dexamethasone

Vincristine

Inotuzumab

Blinatumomab

Dasatinib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information